52 Participants Needed

Sleep Deprivation for Depression

MB
CD
Overseen ByChristine DeLorenzo, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial involves keeping participants with depression awake to see if it temporarily improves their mood. Brain scans will be used to study changes in brain chemistry. The goal is to understand how sleep patterns affect depression and find better treatments. Sleep deprivation has been investigated as a treatment for depression for a long time and is known to produce next-day antidepressant effects.

Will I have to stop taking my current medications?

Yes, you will need to stop taking medications that affect glutamate levels or circadian rhythms, such as stimulants, anti-epileptics, antidepressants, beta-blockers, hypnotics, melatonin, or medications with glutamateric or GABAergic actions, at least 4 weeks before the study and throughout its duration.

What data supports the effectiveness of the treatment Sleep Deprivation for Depression?

Research shows that sleep deprivation can improve mood in about 60% of people with depression, often providing faster results than other treatments. However, the positive effects are usually temporary, and mood may worsen after a recovery night.12345

Is sleep deprivation therapy safe for humans?

Sleep deprivation therapy has been studied primarily for depression, and while it can have an antidepressant effect, it may lead to relapses after sleep is resumed. There is no clear evidence of serious safety concerns, but the mechanism of action is not fully understood, and it should be used with caution.13678

How does sleep deprivation treatment differ from other treatments for depression?

Sleep deprivation treatment for depression is unique because it involves keeping patients awake for a period of time, either partially or totally, to improve mood, unlike typical treatments that often involve medication. It is particularly useful for patients who do not respond to drugs, and its effects can be seen quickly, although it often requires additional therapy to maintain the benefits.6791011

Eligibility Criteria

This study is for adults over 18 with Major Depressive Disorder (MDD) currently experiencing a major depressive episode. Participants must be able to consent, sign a form, and score at least 29 on the MADRS. They can't join if they consume too much caffeine or alcohol, have irregular sleep/wake cycles, are pregnant/lactating/planning pregnancy, have MRI/PET scan contraindications, use certain medications/substances including nicotine or are at risk of suicide.

Inclusion Criteria

Consent form signed
Score of at least twenty-nine on the MADRS (depressed participants only)
I have been diagnosed with major depressive disorder and am currently experiencing a major depressive episode.
See 1 more

Exclusion Criteria

Any PET contraindications, including if study imaging will result in the participant receiving greater exposure than the research limit, or if participant is currently breastfeeding
Participant considered at significant risk for suicide
Any MRI contraindications, including metal implants, pacemaker, metal prostheses, orthodontic appliances, or presence of shrapnel that are contraindicated for MRI
See 13 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Initial Assessment

Participants undergo initial assessment of circadian phase and brain chemistry using PET scans and melatonin measurements

8 weeks
4 overnight stays (in-person)

Sleep Deprivation Therapy

Participants undergo sleep deprivation therapy followed by melatonin and depression severity assessments

1 week
2 overnight stays (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Sleep Deprivation
Trial Overview The trial investigates how disrupting the sleep/wake cycle affects depression by keeping participants awake for one night. It aims to understand circadian rhythm's role in depression and uses brain scans to study brain chemistry changes. Afterward, depressed participants receive free antidepressant medication.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stony Brook University

Lead Sponsor

Trials
225
Recruited
41,700+

Findings from Research

A systematic review of 8 controlled studies involving 368 patients found that sleep deprivation (SD) combined with standard treatment did not significantly reduce depressive symptoms compared to standard treatment alone, with a standardized mean difference of -0.29.
Post hoc analysis suggested that excluding elderly patients revealed a significant short-term effect of SD on depressive symptoms, but this effect diminished after two weeks, indicating that while SD may have transient benefits, its overall efficacy compared to other treatments remains uncertain.
Sleep deprivation as treatment for depression: Systematic review and meta-analysis.Ioannou, M., Wartenberg, C., Greenbrook, JTV., et al.[2021]
Acute sleep deprivation (SD) can improve mood in about 60% of depressed patients the following day, making it one of the fastest-acting treatments for depression, even quicker than electroconvulsive therapy.
Despite its mood-enhancing effects, the underlying mechanisms of how sleep deprivation improves mood in depression are still not fully understood, and insomnia remains a significant risk factor for developing depression.
Sleep deprivation and antidepressant treatment.Voderholzer, U.[2021]
In a 25-day trial involving 18 patients with treatment-resistant depression, periodic sleep deprivation combined with ongoing medication showed better results than medication alone, suggesting a potential enhancement in treatment efficacy.
Some patients experienced rapid recovery after just one or a few sessions of sleep deprivation, indicating that this approach may accelerate remission from depressive episodes.
Periodic sleep deprivation in drug-refractory depression.Dessauer, M., Goetze, U., Tölle, R.[2018]

References

Sleep deprivation as treatment for depression: Systematic review and meta-analysis. [2021]
Sleep deprivation and antidepressant treatment. [2021]
Periodic sleep deprivation in drug-refractory depression. [2018]
Microsleep during partial sleep deprivation in depression. [2019]
Polysomnography and criteria for the antidepressant response to sleep deprivation. [2018]
Sleep deprivation therapy. [2019]
Sleep deprivation therapy. [2013]
The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. [2005]
[Total and partial sleep deprivation in the treatment of depression: preliminary communication]. [2006]
10.United Statespubmed.ncbi.nlm.nih.gov
Meta-analysis of sleep deprivation in the acute treatment of bipolar depression. [2022]
Usage of Therapeutic Sleep Deprivation: A Survey in Psychiatric Hospitals in Austria, Germany, and Switzerland. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security